Search Results - Kenneth Locke, Jr., PhD

Long-term Survival Analysis From PERLA, A Phase II Randomized Trial of Dostarlimab With Chemotherapy Versus Pembrolizumab With Chemotherapy in Metastatic Nonsquamous NSCLC by Sun Min Lim, MD, PhD, Ana Laura Ortega Granados, MD, Gustavo dix Junqueira Pinto, MD, MSc, Christian Sebastián Fuentes, MD, Giuseppe Lo Russo, MD, Michael Schenker, MD, Jin Seok Ahn, MD, PhD, Filippo de Marinis, MD, Kenneth Locke, Jr., PhD, Zsolt Szijgyarto, PhD, Elena Buss, MSc, Neda Stjepanovic, MD, PhD, Ivan Diaz-Padilla, MD, PhD, Solange Peters, MD, PhD

Get full text